FindTrial
Sign In

Tissue biopsy

PROCEDURE9 trials

Sponsors

National Institute of Dental and Craniofacial Research (NIDCR), Ramathibodi Hospital, M.D. Anderson Cancer Center, King's College London, Mayo Clinic

Conditions

Bladder CancerEndometrial CancerHealthyHigh Grade Neuroendocrine NeoplasmsHyperalgesiaImmunotherapyKennedy's DiseaseLong Covid-19

Phase 2

Influence of Genetics in Pain Sensitivity
CompletedNCT00001956
National Institute of Dental and Craniofacial Research (NIDCR)Healthy, Hyperalgesia, Pain
Start: 2000-01-31End: 2005-02-28Target: 800Updated: 2006-06-30
Cabozantinib in High Grade Neuroendocrine Neoplasms
Active, not recruitingNCT04412629
Washington University School of MedicineHigh Grade Neuroendocrine Neoplasms
Start: 2020-11-24End: 2027-03-31Updated: 2026-09-16

Phase 4

Effect of Goserelin (Zoladex®) in Spinal and Bulbar Muscular Atrophy
CompletedNCT00851461
Ramathibodi HospitalKennedy's Disease, Spinobulbar Muscular Atrophy
Start: 2008-04-30End: 2013-11-30Updated: 2015-05-21

Unknown Phase

Improving Clinical Staging for Muscle Invasive Bladder Cancer Through Molecular Profiling and Improved Imaging
CompletedNCT02203136
M.D. Anderson Cancer CenterBladder Cancer
Start: 2014-06-25End: 2019-05-16Updated: 2019-05-22
Muscle Connective Tissue in Limb Development and Disease
RecruitingNCT02611089
King's College LondonRadial Dysplasia
Start: 2016-02-20End: 2036-08-31Target: 150Updated: 2025-08-27
Genetic Biomarker Discovery for Metastatic Prostate Cancer
CompletedNCT03228810
Mayo ClinicProstate Cancer
Start: 2017-05-02End: 2019-04-09Updated: 2019-05-09
LOng COvid COmorbidities: Endocrine,Metabolic,Neuropsychiatric,Muscle,Cardiovascular,Pulmonary,Dermatologic Dysfunctions
RecruitingNCT05293366
Federico II UniversityLong Covid-19
Start: 2022-01-27End: 2027-01-27Target: 100Updated: 2025-08-08
Immunohistochemistry Role in Better Prognosis of Endometrial Carcinoma Patients
CompletedNCT06148129
Zagazig UniversityEndometrial Cancer
Start: 2019-01-12End: 2022-03-01Updated: 2023-11-28
Exploration of the Dynamic Changes and Mechanisms of the Immune Microenvironment in Advanced Colorectal Cancer Treated With IBI363 Combination Therapy
RecruitingNCT06946745
jianming xuImmunotherapy
Start: 2024-12-02End: 2028-12-31Target: 50Updated: 2025-04-27

Related Papers

Cabozantinib in high-grade neuroendocrine neoplasms.
Journal of Clinical Oncology2026-05-27